Effect of FCGR2A and FCGR3A variants on CLL outcome. [electronic resource]
Producer: 20101221Description: 4212-22 p. digitalISSN:- 1528-0020
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- pharmacokinetics
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cyclophosphamide -- therapeutic use
- Disease-Free Survival
- Female
- Genotype
- Humans
- Leukemia, Lymphocytic, Chronic, B-Cell -- diagnosis
- Male
- Middle Aged
- Polymorphism, Single Nucleotide -- genetics
- Prognosis
- Receptors, IgG -- genetics
- Rituximab
- Treatment Outcome
- Vidarabine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.